# Fetal Middle Cerebral Artery Doppler in Preterm Births Receiving Magnesium Sulfate for Neuroprotection

> **NCT02506894** · EARLY_PHASE1 · COMPLETED · sponsor: **Cairo University** · enrollment: 60 (actual)

## Conditions studied

- Preterm Birth

## Interventions

- **DRUG:** Magnesium Sulfate
- **OTHER:** 0.9% sodium chloride solution

## Key facts

- **NCT ID:** NCT02506894
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02506894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02506894, "Fetal Middle Cerebral Artery Doppler in Preterm Births Receiving Magnesium Sulfate for Neuroprotection". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02506894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*